Literature DB >> 23716353

A pilot study of muscle plasma protein changes after exercise.

Julia R Dahlqvist1, Line G Voss, Thomas Lauridsen, Thomas O Krag, John Vissing.   

Abstract

INTRODUCTION: Creatine kinase (CK) and myoglobin (Mb) do not possess all good qualities as biomarkers of skeletal muscle damage. We investigated the utility of troponin I (TnI) and telethonin (Tcap) as markers and examined their temporal profiles after skeletal muscle damage.
METHODS: Plasma profiles were measured before and after exercise in 3 groups: subjects affected by either Becker muscular dystrophy or McArdle disease, and healthy subjects.
RESULTS: Mb and TnI appeared early in the blood, and the increase of TnI was only observed in patients with muscle disease. The CK increase was more delayed in plasma. Tcap was not detectable at any time.
CONCLUSIONS: Our results suggest that TnI is a marker of more severe damage signifying sarcomeric damage, and it could therefore be an important supplement to CK and Mb in clinical practice. Tcap is not useful as a marker for skeletal muscle damage.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  creatine kinase; exercise-induced muscle damage; myoglobin; skeletal troponin I; telethonin

Mesh:

Substances:

Year:  2013        PMID: 23716353     DOI: 10.1002/mus.23909

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  7 in total

1.  Rapid upregulation and clearance of distinct circulating microRNAs after prolonged aerobic exercise.

Authors:  Aaron L Baggish; Joseph Park; Pil-Ki Min; Stephanie Isaacs; Beth A Parker; Paul D Thompson; Chris Troyanos; Pierre D'Hemecourt; Sophia Dyer; Marissa Thiel; Andrew Hale; Stephen Y Chan
Journal:  J Appl Physiol (1985)       Date:  2014-01-16

2.  Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.

Authors:  Kitipong Uaesoontrachoon; James L Quinn; Kathleen S Tatem; Jack H Van Der Meulen; Qing Yu; Aditi Phadke; Brittany K Miller; Heather Gordish-Dressman; Ennio Ongini; Daniela Miglietta; Kanneboyina Nagaraju
Journal:  Hum Mol Genet       Date:  2014-01-23       Impact factor: 6.150

3.  Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.

Authors:  Roberta Francesca Capogrosso; Paola Mantuano; Kitipong Uaesoontrachoon; Anna Cozzoli; Arcangela Giustino; Todd Dow; Sadish Srinivassane; Marina Filipovic; Christina Bell; Jack Vandermeulen; Ada Maria Massari; Michela De Bellis; Elena Conte; Sabata Pierno; Giulia Maria Camerino; Antonella Liantonio; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.834

4.  The Oxidative Stress Response in Elite Water Polo Players: Effects of Genetic Background.

Authors:  Mercurio Vecchio; Monica Currò; Fabio Trimarchi; Sergio Naccari; Daniela Caccamo; Riccardo Ientile; Davide Barreca; Debora Di Mauro
Journal:  Biomed Res Int       Date:  2017-07-04       Impact factor: 3.411

5.  Time Course and Association of Functional and Biochemical Markers in Severe Semitendinosus Damage Following Intensive Eccentric Leg Curls: Differences between and within Subjects.

Authors:  Gerard Carmona; Jurdan Mendiguchía; Xavier Alomar; Josep M Padullés; David Serrano; Lexa Nescolarde; Gil Rodas; Roser Cussó; Ramón Balius; Joan A Cadefau
Journal:  Front Physiol       Date:  2018-02-05       Impact factor: 4.566

6.  The Blood and Muscle Expression Pattern of the Equine TCAP Gene during the Race Track Training of Arabian Horses.

Authors:  Monika Stefaniuk-Szmukier; Tomasz Szmatoła; Joanna Łątka; Bogusława Długosz; Katarzyna Ropka-Molik
Journal:  Animals (Basel)       Date:  2019-08-18       Impact factor: 2.752

Review 7.  Biomarkers in Glycogen Storage Diseases: An Update.

Authors:  Alberto Molares-Vila; Alberte Corbalán-Rivas; Miguel Carnero-Gregorio; José Luís González-Cespón; Carmen Rodríguez-Cerdeira
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.